| For: | Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006; 12(37): 6041-6045 [PMID: 17009406 DOI: 10.3748/wjg.v12.i37.6041] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i37/6041.htm |
| Number | Citing Articles |
| 1 |
Hsi-Wen Yeh, Szu-Shuo Lee, Chieh-Yu Chang, Yaw-Dong Lang, Yuh-Shan Jou. A New Switch for TGFβ in Cancer. Cancer Research 2019; 79(15) doi: 10.1158/0008-5472.CAN-18-2019
|
| 2 |
Kai Ma, Baoping Cao, Mingzhou Guo. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0210-9
|
| 3 |
L Du, Z Zhao, X Ma, T-H Hsiao, Y Chen, E Young, M Suraokar, I Wistuba, J D Minna, A Pertsemlidis. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene 2014; 33(34) doi: 10.1038/onc.2013.381
|
| 4 |
Robert Moore, Kathy Qi Cai, Wensi Tao, Elizabeth R Smith, Xiang-Xi Xu. Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Developmental Biology 2013; 13(1) doi: 10.1186/1471-213X-13-39
|
| 5 |
Domenico Azarnia Tehran, Tania López-Hernández, Tanja Maritzen. Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations. Cells 2019; 8(11) doi: 10.3390/cells8111345
|
| 6 |
Grégoire F. Le Bras, Kenneth J. Taubenslag, Claudia D. Andl. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adhesion & Migration 2012; 6(4) doi: 10.4161/cam.21326
|
| 7 |
Ya-Fei Xu, Yan-Ping Mao, Ying-Qin Li, Xian-Yue Ren, Qing-Mei He, Xin-Ran Tang, Ying Sun, Na Liu, Jun Ma. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. Cancer Letters 2015; 363(2) doi: 10.1016/j.canlet.2015.04.006
|
| 8 |
Gaoda Ju, Lingling Zhang, Wenting Guo, Hao Wang, Xin Zhang, Zhuanzhuan Mu, Yuqing Sun, Di Sun, Han Diao, Sen Miao, Yiran Chen, Tao Xing, Jun Liang, Yansong Lin, Wei Long Zhong. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma. Disease Markers 2022; 2022 doi: 10.1155/2022/1686316
|
| 9 |
Beata Pyrzynska, Iwona Pilecka, Marta Miaczynska. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Molecular Oncology 2009; 3(4) doi: 10.1016/j.molonc.2009.06.001
|
| 10 |
Marc S. Penn. Are stem cells the teacher or the student?. Current Opinion in Organ Transplantation 2012; 17(6) doi: 10.1097/MOT.0b013e32835a5aad
|
| 11 |
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, Disha D. Shah, Kunal G. Maheshwari, Mehul R. Chorawala. RETRACTED ARTICLE: Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution. Cell Biochemistry and Biophysics 2024; 82(2) doi: 10.1007/s12013-024-01261-5
|
| 12 |
XUE-MEI XIE, ZI-YIN ZHANG, LIAN-HE YANG, DA-LEI YANG, NA TANG, HUAN-YU ZHAO, HONG-TAO XU, QING-CHANG LI, EN-HUA WANG. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. International Journal of Oncology 2013; 43(5) doi: 10.3892/ijo.2013.2084
|
| 13 |
Joanna H Tong, David C Ng, Shuk L Chau, Ken K So, Patrick P Leung, Tin L Lee, Raymond W Lung, Michael W Chan, Anthony W Chan, Kwok W Lo, Ka F To. Putative tumour-suppressor gene DAB2is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-253
|
| 14 |
Adèle Hannigan, Paul Smith, Gabriela Kalna, Cristiana Lo Nigro, Clare Orange, Darren I. O’Brien, Reshma Shah, Nelofer Syed, Lindsay C. Spender, Blanca Herrera, Johanna K. Thurlow, Laura Lattanzio, Martino Monteverde, Meghan E. Maurer, Francesca M. Buffa, Jelena Mann, David C.K. Chu, Catharine M.L. West, Max Patridge, Karin A. Oien, Jonathan A. Cooper, Margaret C. Frame, Adrian L. Harris, Louise Hiller, Linda J. Nicholson, Milena Gasco, Tim Crook, Gareth J. Inman. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter. Journal of Clinical Investigation 2010; 120(8) doi: 10.1172/JCI36125
|
| 15 |
Zoe K. Price, Noor A. Lokman, Masato Yoshihara, Hiroaki Kajiyama, Martin K. Oehler, Carmela Ricciardelli. Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways. International Journal of Molecular Sciences 2022; 24(1) doi: 10.3390/ijms24010696
|
| 16 |
Alicia A. Tone, Carl Virtanen, Patricia Shaw, Theodore J. Brown. Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis. Clinical Cancer Research 2012; 18(16) doi: 10.1158/1078-0432.CCR-12-0199
|
| 17 |
S Liu, N Zhu, H Chen. Expression patterns of human DAB2IP protein in fetal tissues. Biotechnic & Histochemistry 2012; 87(5) doi: 10.3109/10520295.2012.664658
|
| 18 |
O. I. Kit, D. I. Vodolazhskiy, E. N. Kolesnikov, N. N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylation. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(1) doi: 10.1134/S1990750817010048
|
| 19 |
Chang Li, Jun Chen, Tengfei Chen, Zhenlei Xu, Chun Xu, Cheng Ding, Yuxuan Wang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao. Aberrant Hypermethylation at Sites -86 to 226 of DAB2 Gene in Non-Small Cell Lung Cancer. The American Journal of the Medical Sciences 2015; 349(5) doi: 10.1097/MAJ.0000000000000436
|
| 20 |
J. Chen, D. L. Kwong, T. Cao, Q. Hu, L. Zhang, X. Ming, J. Chen, L. Fu, X. Guan. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Diseases of the Esophagus 2015; 28(1) doi: 10.1111/dote.12088
|
| 21 |
Chang Li, Cheng Ding, Tengfei Chen, Jun Chen, Zhenlei Xu, Zhe Lei, Chun Xu, Jun Zhao. Micro ribonucleic acid‐93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2. Thoracic Cancer 2015; 6(4) doi: 10.1111/1759-7714.12242
|
| 22 |
Antoine G. van der Heijden, Lourdes Mengual, Juan J. Lozano, Mercedes Ingelmo-Torres, Maria J. Ribal, Pedro L. Fernández, Egbert Oosterwijk, Jack A. Schalken, Antonio Alcaraz, J. Alfred Witjes. A five-gene expression signature to predict progression in T1G3 bladder cancer. European Journal of Cancer 2016; 64 doi: 10.1016/j.ejca.2016.06.003
|
| 23 |
J C Martin, B-S Herbert, B A Hocevar. Disabled-2 downregulation promotes epithelial-to-mesenchymal transition. British Journal of Cancer 2010; 103(11) doi: 10.1038/sj.bjc.6605975
|
| 24 |
Jose A. Karam, Shahrokh F. Shariat, Hong-Ying Huang, Rey-Chen Pong, Raheela Ashfaq, Ellen Shapiro, Yair Lotan, Arthur I. Sagalowsky, Xue-Ru Wu, Jer-Tsong Hsieh. Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder. Clinical Cancer Research 2007; 13(15) doi: 10.1158/1078-0432.CCR-07-0287
|
| 25 |
Showket Hussain, Neha Singh, Irfana Salam, Kapil Bandil, M Yuvaraj, Mohammad Akbar Bhat, Mohammad Muzaffar Mir, Mushtaq A. Siddiqi, Ranbir C Sobti, Mausumi Bharadwaj, Bhudev C. Das. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. Journal of Receptors and Signal Transduction 2011; 31(2) doi: 10.3109/10799893.2011.553836
|
| 26 |
Wensi Tao, Robert Moore, Elizabeth R. Smith, Xiang-Xi Xu. Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00129
|
| 27 |
Ovidio Jiménez Martín, Andreas Schlosser, Rhoikos Furtwängler, Jenny Wegert, Manfred Gessler. MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02259-2
|
| 28 |
Hong-Tao Xu, Lian-He Yang, Qing-Chang Li, Shu-Li Liu, Di Liu, Xue-Mei Xie, En-Hua Wang. Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers. Human Pathology 2011; 42(10) doi: 10.1016/j.humpath.2011.01.004
|
| 29 |
Chen-Shuan Chung, Yi-Chia Lee, Cheng-Ping Wang, Jenq-Yuh Ko, Wen-Lun Wang, Ming-Shiang Wu, Hsiu-Po Wang. Secondary Prevention of Esophageal Squamous Cell Carcinoma in Areas Where Smoking, Alcohol, and Betel Quid Chewing are Prevalent. Journal of the Formosan Medical Association 2010; 109(6) doi: 10.1016/S0929-6646(10)60072-1
|
| 30 |
Yu Liu, Lili Du, Shifeng Gu, Jingying Liang, Minshan Huang, Lijun Huang, Siying Lai, Shuang Zhang, Zhaowei Tu, Wei Sun, Dunjin Chen, Jingsi Chen. Identification of the role of DAB2 and CXCL8 in uterine spiral artery remodeling in early-onset preeclampsia. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05212-4
|
| 31 |
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signaling. BioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
|
| 32 |
Shantel B. Ternes, Matthew J. Rowling. Vitamin D Transport Proteins Megalin and Disabled-2 Are Expressed in Prostate and Colon Epithelial Cells and Are Induced and Activated by All-Trans-Retinoic Acid. Nutrition and Cancer 2013; 65(6) doi: 10.1080/01635581.2013.805422
|
| 33 |
O.I. Kit, D.I. Vodolazhskiy, E.N. Kolesnikov, N.N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylation. Biomeditsinskaya Khimiya 2016; 62(5) doi: 10.18097/PBMC20166205520
|
| 34 |
Yujuan Yang, Qingxia Zhang, Feng Xu, Chunkang Chang, Xiao Li. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome. European Journal of Haematology 2012; 89(6) doi: 10.1111/ejh.12014
|
| 35 |
Chien‐Ling Huang, Ju‐Chien Cheng, Kenji Kitajima, Toru Nakano, Chun‐Fung Yeh, Kowit‐Yu Chong, Ching‐Ping Tseng. Disabled‐2 is required for mesoderm differentiation of murine embryonic stem cells. Journal of Cellular Physiology 2010; 225(1) doi: 10.1002/jcp.22200
|
| 36 |
Andrew M. Kaz, William M. Grady. Epigenetic biomarkers in esophageal cancer. Cancer Letters 2014; 342(2) doi: 10.1016/j.canlet.2012.02.036
|
| 37 |
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signaling. BioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
|
| 38 |
Jaroslaw Paluszczak, Katarzyna Kiwerska, Daniela Mielcarek-Kuchta. Frequent methylation of DAB2, a Wnt pathway antagonist, in oral and oropharyngeal squamous cell carcinomas. Pathology - Research and Practice 2018; 214(2) doi: 10.1016/j.prp.2017.12.010
|
| 39 |
Stella C. Ogbu, Phillip R. Musich, Jinyu Zhang, Zhi Q. Yao, Philip H. Howe, Yong Jiang. The role of disabled-2 (Dab2) in diseases. Gene 2021; 769 doi: 10.1016/j.gene.2020.145202
|
| 40 |
Roman Muff, Ram Mohan Ram Kumar, Sander M. Botter, Walter Born, Bruno Fuchs. Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems. Sarcoma 2012; 2012 doi: 10.1155/2012/937506
|
| 41 |
Xiao-Mei Zhang, Ming-Zhou Guo. The value of epigenetic markers in esophageal cancer. Frontiers of Medicine in China 2010; 4(4) doi: 10.1007/s11684-010-0230-3
|
| 42 |
Wen-Lun Wang, Wei-Lun Chang, Hsiao-Bai Yang, Yu-Chi Wang, I-Wei Chang, Ching-Tai Lee, Chi-Yang Chang, Jaw-Town Lin, Bor-Shyang Sheu. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma. Oncotarget 2016; 7(44) doi: 10.18632/oncotarget.8460
|
| 43 |
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Flaming the fight against cancer cells: the role of microRNA-93. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01349-x
|
| 44 |
Paulette Mhawech-Fauceglia, Joshua Kesterson, Dan Wang, Stacey Akers, Nefertiti Chianti DuPont, Kimberly Clark, Shashikant Lele, Song Liu. Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer. Histopathology 2011; 59(1) doi: 10.1111/j.1365-2559.2011.03892.x
|